Disease Molecular Biology Small Molecule Workshop 
Drug Discovery World
FEBRUARY 27, 2023
RT : A key challenge that has emerged is targeting a known RNA transcript associated with an “undruggable disease” with no knowledge of where to start on the transcript, more specifically, which parts of the transcript are even targetable through various therapeutic modalities. By Is there anything currently in the pipeline?
Drug Discovery World
NOVEMBER 15, 2022
The brainchild of multidisciplinary experts in computer science, physics, engineering, and biology, the field of synthetic biology has not only rapidly progressed in the last few decades but it’s also becoming more accessible and cost-effective. Finding promising antibodies against specific molecular targets, however, is no easy feat.
Expert insights. Personalized for you.
130 
Let's personalize your content